Ildong Pharmaceutical Co., Ltd. (KRX:249420)
27,350
-50 (-0.18%)
Apr 29, 2026, 3:30 PM KST
Ildong Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 64,845 | 72,267 | 53,258 | 52,146 | 135,586 | Upgrade
|
| Short-Term Investments | 110 | 12,605 | 28,021 | 16,600 | 19,095 | Upgrade
|
| Trading Asset Securities | - | - | - | 10,000 | - | Upgrade
|
| Cash & Short-Term Investments | 64,955 | 84,872 | 81,279 | 78,746 | 154,681 | Upgrade
|
| Cash Growth | -23.47% | 4.42% | 3.22% | -49.09% | 79.52% | Upgrade
|
| Accounts Receivable | 46,852 | 44,613 | 56,245 | 53,916 | 51,818 | Upgrade
|
| Other Receivables | 3,576 | 10,073 | 2,735 | 4,158 | 3,026 | Upgrade
|
| Receivables | 51,096 | 66,977 | 62,650 | 58,074 | 54,844 | Upgrade
|
| Inventory | 100,524 | 87,939 | 84,623 | 98,249 | 82,587 | Upgrade
|
| Prepaid Expenses | 578.69 | 2,150 | 1,623 | 1,270 | 1,363 | Upgrade
|
| Other Current Assets | 4,812 | 5,053 | 5,506 | 45,697 | 7,008 | Upgrade
|
| Total Current Assets | 221,965 | 246,991 | 235,681 | 282,035 | 300,485 | Upgrade
|
| Property, Plant & Equipment | 220,696 | 221,443 | 256,380 | 255,317 | 247,790 | Upgrade
|
| Long-Term Investments | 47,696 | 23,729 | 18,996 | 21,395 | 22,432 | Upgrade
|
| Goodwill | 5,527 | 5,527 | 5,527 | 5,527 | 5,527 | Upgrade
|
| Other Intangible Assets | 17,163 | 22,681 | 30,079 | 31,401 | 38,926 | Upgrade
|
| Long-Term Accounts Receivable | - | 277.34 | 442.14 | 542.83 | - | Upgrade
|
| Long-Term Deferred Tax Assets | 46,708 | 55,670 | 53,888 | 43,822 | 66,016 | Upgrade
|
| Long-Term Deferred Charges | 6,122 | 6,151 | 6,505 | 10,193 | 22,174 | Upgrade
|
| Other Long-Term Assets | 6,096 | 4,590 | 1,689 | 3,630 | 3,808 | Upgrade
|
| Total Assets | 573,031 | 589,043 | 611,261 | 655,810 | 708,970 | Upgrade
|
| Accounts Payable | 47,761 | 47,616 | 50,250 | 46,099 | 38,334 | Upgrade
|
| Accrued Expenses | 27,749 | 30,985 | 33,277 | 33,734 | 34,930 | Upgrade
|
| Short-Term Debt | 82,413 | 122,647 | 176,497 | 140,743 | 88,400 | Upgrade
|
| Current Portion of Long-Term Debt | 33,535 | 3,443 | 13,000 | 1,000 | 42,000 | Upgrade
|
| Current Portion of Leases | 4,878 | 4,606 | 3,575 | 6,618 | 4,035 | Upgrade
|
| Current Income Taxes Payable | 986.98 | 1,475 | 68.3 | 268.05 | 7.55 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 600 | Upgrade
|
| Other Current Liabilities | 27,745 | 57,969 | 64,728 | 82,182 | 149,456 | Upgrade
|
| Total Current Liabilities | 225,069 | 268,739 | 341,395 | 310,644 | 357,763 | Upgrade
|
| Long-Term Debt | 2,673 | 56,208 | 3,000 | 16,000 | 60,404 | Upgrade
|
| Long-Term Leases | 20,908 | 18,644 | 16,654 | 43,387 | 31,316 | Upgrade
|
| Pension & Post-Retirement Benefits | 67,547 | 66,150 | 62,185 | 72,215 | 82,149 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 372.56 | 393.05 | 1.43 | 6.06 | - | Upgrade
|
| Other Long-Term Liabilities | 11,047 | 12,623 | 8,644 | 9,688 | 10,375 | Upgrade
|
| Total Liabilities | 327,617 | 422,758 | 431,880 | 451,940 | 542,008 | Upgrade
|
| Common Stock | 31,638 | 28,063 | 28,063 | 26,803 | 23,803 | Upgrade
|
| Additional Paid-In Capital | 95,380 | 173,327 | 173,359 | 377,287 | 210,262 | Upgrade
|
| Retained Earnings | 105,717 | -50,942 | -58,540 | -211,102 | -81,951 | Upgrade
|
| Treasury Stock | -2,308 | -2,307 | -2,307 | -365.05 | -365.05 | Upgrade
|
| Comprehensive Income & Other | 15,995 | 12,618 | 28,968 | -1,379 | 1,159 | Upgrade
|
| Total Common Equity | 246,422 | 160,758 | 169,543 | 191,244 | 152,909 | Upgrade
|
| Minority Interest | -6,909 | -1,701 | 4,723 | 6,981 | 7,676 | Upgrade
|
| Shareholders' Equity | 245,414 | 166,285 | 179,381 | 203,870 | 166,962 | Upgrade
|
| Total Liabilities & Equity | 573,031 | 589,043 | 611,261 | 655,810 | 708,970 | Upgrade
|
| Total Debt | 144,408 | 205,548 | 212,726 | 207,748 | 226,155 | Upgrade
|
| Net Cash (Debt) | -79,452 | -120,675 | -131,447 | -129,002 | -71,474 | Upgrade
|
| Net Cash Per Share | -2585.64 | -4320.27 | -4862.98 | -4896.88 | -3004.97 | Upgrade
|
| Filing Date Shares Outstanding | 31.51 | 27.93 | 27.93 | 26.79 | 23.79 | Upgrade
|
| Total Common Shares Outstanding | 31.51 | 27.93 | 27.93 | 26.79 | 23.79 | Upgrade
|
| Working Capital | -3,104 | -21,748 | -105,713 | -28,609 | -57,279 | Upgrade
|
| Book Value Per Share | 7820.92 | 5755.27 | 6069.76 | 7139.87 | 6428.69 | Upgrade
|
| Tangible Book Value | 223,732 | 132,550 | 133,936 | 154,315 | 108,456 | Upgrade
|
| Tangible Book Value Per Share | 7100.80 | 4745.41 | 4795.03 | 5761.20 | 4559.77 | Upgrade
|
| Land | 50,816 | 50,816 | 72,561 | 35,125 | 35,125 | Upgrade
|
| Buildings | 142,902 | 140,049 | 141,614 | 140,941 | 140,732 | Upgrade
|
| Machinery | 197,365 | 202,503 | 211,982 | 206,257 | 195,601 | Upgrade
|
| Construction In Progress | 1,471 | 1,393 | 3,694 | 1,963 | 3,683 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.